🟢 Quantum BioPharma is trading 6.48% up in pre-market — no clear company-specific catalyst identified

Quantum BioPharma is trading at $3.45, up +6.48%, amid catalyst-unclear speculative or technical pre-market activity.

• No new company-specific announcement dated September 8, 2026 was identified; the latest official releases found were the August 10 FDA clearance and August 21 corporate update.
• Broader markets are mixed, with the NASDAQ Composite up 0.29%, insufficient to establish a market-wide explanation.